alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5547 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 5547

   To amend title XI of the Social Security Act to protect access to 
                   genetically targeted technologies.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 18, 2023

 Mr. Nickel (for himself, Mr. Joyce of Pennsylvania, and Mr. Davis of 
 North Carolina) introduced the following bill; which was referred to 
the Committee on Energy and Commerce, and in addition to the Committee 
 on Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
   To amend title XI of the Social Security Act to protect access to 
                   genetically targeted technologies.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Maintaining Investments in New 
Innovation Act''.

SEC. 2. AMENDMENT TO DEFINITION OF QUALIFYING SINGLE SOURCE DRUG.

    Section 1192(e) of the Social Security Act (42 U.S.C. 1320f-1(e)) 
is amended--
            (1) in paragraph (1)(A)(ii), by inserting ``(or, in the 
        case of an advanced drug product (as defined in paragraph (4)), 
        11 years)'' after ``7 years''; and
            (2) by adding at the end the following new paragraph:
            ``(4) Advanced drug product defined.--For purposes of 
        paragraph (1)(A)(ii), the term `advanced drug product' means a 
        drug that incorporates or utilizes a genetically targeted 
        technology (as defined in section 529A(c)(2) of the Federal 
        Food, Drug, and Cosmetic Act) that may result in the modulation 
        (including suppression, up-regulation, or activation) of the 
        function of a gene or its associated gene product.''.
                                 <all>
```
ARMED SERVICES BOARD OF CONTRACT APPEALS

Appeal of - )

)

Allied Pacific Builders ) ASBCA No. 63452

)

Under Contract No. N62478-20-D-4033 )

APPEARANCE FOR THE APPELLANT: Mr. William Alicar

 President

APPEARANCES FOR THE GOVERNMENT: Craig D. Jensen, Esq.

 Navy Chief Trial Attorney

David M. Marquez, Esq.

 Trial Attorney

ORDER OF DISMISSAL

The dispute has been settled. The appeal is dismissed with prejudice.

Dated: May 24, 2023

I certify that the foregoing is a true copy of the Order of Dismissal of the Armed 

Services Board of Contract Appeals in ASBCA No. 63452, Appeal of Allied Pacific 

Builders, rendered in conformance with the Board’s Charter.

Dated: May 25, 2023

RICHARD SHACKLEFORD

Administrative Judge

Acting Chairman

Armed Services Board

of Contract Appeals

PAULLA K. GATES-LEWIS

Recorder, Armed Services

Board of Contract Appeals
I 

118TH CONGRESS 

1ST SESSION H. R. 5598 

To amend the SUPPORT for Patients and Communities Act to reauthorize 

a youth prevention and recovery initiative. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 20, 2023 

Ms. LEE of Nevada (for herself and Mrs. KIGGANS of Virginia) introduced the 

following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each 

case for consideration of such provisions as fall within the jurisdiction of 

the committee concerned 

A BILL 

To amend the SUPPORT for Patients and Communities 

Act to reauthorize a youth prevention and recovery initiative. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Treatment, Recovery, 

5 Education, Awareness, and Training for Youth Act’’ or 

6 the ‘‘TREAT Youth Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 5598 IH

1 SEC. 2. YOUTH PREVENTION AND RECOVERY. 

2 Section 7102(c)(9) of the SUPPORT for Patients 

3 and Communities Act (42 U.S.C. 290bb–7a(c)(9)) is 

4 amended by striking ‘‘fiscal years 2019 through 2023’’ 

5 and inserting ‘‘fiscal years 2024 through 2028’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Extension Agreement for Notes Payable dated May 13, 2010



 Exhibit 10.2 

DMI LIFE SCIENCES, INC. 

EXTENSION AGREEMENT FOR NOTES PAYABLE 

TOTAL PRINCIPAL AMOUNT: $100,000 

May 13, 2010 
 Greenwood Village, Colorado

 On November 12, 2009 and December 4, 2009, the undersigned, DMI Life Sciences, Inc., a Delaware corporation following its
reincorporation in March 2010 (“Maker”) issued two promissory notes, each in the principal amount of $50,000 (the “Notes”) and promised to pay to the order of Michael Macaluso, together with any successors or assigns
(collectively, the “Holder”), the aggregate principal sum of One Hundred Thousand United States Dollars (US $100,000), with interest accruing on the outstanding principal amount of the Notes at an annual rate of six percent
(6.0%) until the Notes are paid in full. The Notes had original due dates of April 30, 2010. 
 In consideration of this agreement and
the extension contemplated hereby and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Maker and the Holder have agreed to extend the due date of the Notes to the earlier of (i) the closing
and receipt by the Maker or its parent, Ampio Pharmaceuticals, Inc., of debt or equity financing totaling $5 million or more, or (ii) September 2, 2010. All of the other terms of the original Notes remain unchanged. 

Maker may prepay the Notes in part, or in full, prior to the due date of the Notes. Payments of principal and interest shall be made at the place that
Holder from time to time shall direct in writing. 
  

			
	 Maker:
 DMI Life
Sciences, Inc.

		
	By:	 	/S/     BRUCE G.
MILLER        
		 	Bruce G. Miller, Chief Financial Officer
	
	 Holder:
 Michael
Macaluso.

		
	By:	 	/S/     MICHAEL MACALUSO
        
		 	Michael Macaluso
[Federal Register Volume 61, Number 84 (Tuesday, April 30, 1996)]
[Notices]
[Page 19083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10645]



-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR
[Docket No. 4310-DN]


Notice of a Public Meeting; Montana, MT-060-06-1020-00

AGENCY: Bureau of Land Management, Lewistown District Office.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Lewistown District Advisory Council will meet May 21 and 
22, 1996, at the 7 Lazy P Guest Ranch, north west of Choteau, Montana. 
The meeting will begin at 8 a.m. on May 21. The business of the day 
will include reviewing a draft letter to interest groups and 
individuals inquiring of the potential for creating a coordinated 
resource management group concerning oil and gas exploration and 
development along the Rocky Mountain Front; reviewing possible options 
to buy back, abandon, or terminate mineral leases along the Front; and 
a field trip to the area being considered for additional exploration.
    On May 22, the meeting will begin at 8 a.m. The topics of the day 
will include standards and guidelines; the council's charter; the Mixed 
Grass Prairie ACEC; mineral exploration proposal in the Bitter Creek 
Wilderness Study Area; black-footed ferret/prairie dog issues; Native 
American participation in council activities; and the nomination 
process for those council positions that expire in 1996.
    There will be a public comment period at 11:30 a.m. on May 22.

DATES: May 21 and 22, 1996.

LOCATION: 7 Lazy P Guest Ranch, northwest of Choteau, Montana.

FOR FURTHER INFORMATION CONTACT: District Manager, Lewistown District 
Office, Bureau of Land Management, P.O. Box 1160, Lewistown, MT 59457.

SUPPLEMENTARY INFORMATION: The meeting is open to the public and there 
will be a public comment period as detailed above.


    Dated: April 16, 1996.
David L. Mari,
District Manager.
[FR Doc. 96-10645 Filed 4-29-96; 8:45 am]
BILLING CODE 4310-84-P
[Federal Register Volume 86, Number 102 (Friday, May 28, 2021)]
[Notices]
[Page 28921]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11502]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Sunshine Act Meetings

TIME AND DATE: Notice is hereby given, pursuant to the provisions of 
the Government in the Sunshine Act, Public Law 94-409, that the 
Securities and Exchange Commission Investor Advisory Committee will 
hold a public meeting on Thursday, June 10, 2021. The meeting will 
begin at 10:00 a.m. (ET) and will be open to the public.

PLACE: The meeting will be conducted by remote means and/or at the 
Commission's headquarters, 100 F St NE, Washington, DC 20549. Members 
of the public may watch the webcast of the meeting on the Commission's 
website at www.sec.gov.

STATUS: This Sunshine Act notice is being issued because a majority of 
the Commission may attend the meeting. On May 26, 2021, the Commission 
published notice of the Committee meeting (Release Nos. 33-10944, 34-
92018), indicating that the meeting is open to the public and inviting 
the public to submit written comments to the Committee.

MATTER TO BE CONSIDERED: The agenda for the meeting includes: Welcome 
remarks; approval of previous meeting minutes; a panel discussion 
regarding best execution and its role in post-NMS market structure; a 
panel discussion regarding best execution issues unique to wholesale 
brokers; a panel discussion regarding 10b5-1 plans; a discussion of a 
recommendation regarding individual retirement accounts; subcommittee 
reports; and a non-public administrative session.

CONTACT PERSON FOR MORE INFORMATION: For further information and to 
ascertain what, if any, matters have been added, deleted or postponed; 
please contact Vanessa A. Countryman from the Office of the Secretary 
at (202) 551-5400.

    Dated: May 26, 2021.
Vanessa A. Countryman,
Secretary.
[FR Doc. 2021-11502 Filed 5-26-21; 4:15 pm]
BILLING CODE 8011-01-P
EXHIBIT 32.1

Certification Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of American Realty Investors, Inc. (the Company), on
Form 10-K for the year ended December 31, 2008 as filed with the Securities Exchange Commission on the date hereof (the Report), the undersigned Daniel J. Moos President and Chief Operating Officer of the Company (Principal
Executive Officer) and Gene S. Bertcher , Executive Vice President and Interim Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company.



|                      |  |                                                                                                     
|--------------------- |  | ----------------------------------------------------------------------------------------------------
|Dated: March 31, 2009 |  | /s/    DANIEL J.
MOOS                                                                               
|                      |  | Daniel J. Moos President and Chief Operating Officer (Principal Executive Officer)                  
|                      | 
|Dated: March 31, 2009 |  | /s/    GENE S.
BERTCHER                                                                             
|                      |  | Gene S. Bertcher Executive Vice President and Chief Accounting Officer (Principal Financial
Officer)
#### Lanric HYLAND, Plaintiff-Appellant, v. Roy L. WONDER, Supervising Judge, Juvenile Court, Superior Court of the City and County of San Francisco, individually and in his official capacity; Daniel M. Hanlon, Presiding Judge, Superior Court of the City and County of San Francisco, individually and in his official capacity; Dennis Sweeney, Chief Probation Officer, San Francisco Juvenile Probation Department, individually and in his official capacity; Fred Jordan, Chief Probation Officer, San Francisco Juvenile Probation Department, individually and in his official capacity; Stephen La Plante, Director, Juvenile Hall, individually and in his official capacity, Defendants-Appellees.

No. 95-15533.

United States Court of Appeals, Ninth Circuit.

Oct. 6, 1997.

Prior report: 117 F.3d 405.

Before: SNEED, BOOCHEVER, AND THOMPSON, Circuit Judges.

The opinion in the above-entitled case, filed June 25, 1997, is amended as follows:

At Slip op. pg. 7353 [117 F.3d at 411, left column, second full paragraph], at the end of the paragraph numbered [3], change the to a “,” and add “and the Navy officer had qualified immunity.” Delete the following sentence at the start of the next paragraph, “That analysis applies here.”

At Slip op. pg. 7355 [117 F.3d at 412, left column, second full paragraph], on the second line of the runover paragraph, change the words “found a First Amendment violation on” to “applied a first amendment analysis to.”

With the opinion thus amended, the panel has unanimously voted to deny the petition for rehearing. Judge Thompson has voted to reject the suggestion for rehearing en banc and Judges Sneed and Boochever so recommend. The full court has been advised of the suggestion for rehearing en banc and no active judge has requested a vote on whether to rehear the matter en banc. Fed.R.App. 35.

The petition for rehearing is DENIED and the suggestion for rehearing en banc is REJECTED.
#### Jennifer L. HEAD, Appellant, v. STATE of Missouri, Respondent.

No. WD 52715.

Missouri Court of Appeals, Western District.

Nov. 26, 1996.

Irene Karns, Asst. Public Defender, Columbia, for appellant.

Jeremiah W. (Jay) Nixon, Attorney General, John M. Morris, Assistant Attorney General, Jefferson City, for respondent.

*39Before SMART, P.J., and SPINDEN and ELLIS, JJ.

*ORDER*

PER CURIAM:

Jennifer L. Head appeals from the denial of her Rule 24.035 motion for postconviction relief.

Judgment affirmed. Rule 84.16(b).
EXHIBIT 10.12



 Exhibit 10.12 

Translation of Medicinal Material Procurement Contract 

Party A (Purchaser): Yunnan Shangri-La Tibetan Pharmaceutical Group Limited 

Party B (Supplier): Xiong Ba 
  

															
	 Product’s Name
	  	Spec	  	Unit	  	Quantity	  	Unit
Price	  	Value (RMB)	  	Procurement
Period	  	Memo
	 Semen Punicae Granati
	  		  	kg	  	32195	  	50.84	  	1,636,824.71	  	09.1.1-12.31	  	
	 Fructus Malvae
	  		  	kg	  	4476	  	162.92	  	729,325.16	  	09.1.1-12.31	  	
	 Asparagus cochinchinensis
	  		  	kg	  	5088	  	27.2	  	138,378.66	  	09.1.1-12.31	  	
	 Tibetan Lengzi Qin
	  		  	kg	  	8398	  	37.15	  	311,997.61	  	09.1.1-12.31	  	
	 Himalayas Four o’clock
	  		  	kg	  	21195	  	37.26	  	789,737.00	  	09.1.1-12.31	  	
	 Puncturevine Caltrop Fruit
	  		  	kg	  	15534	  	42.03	  	652,828.28	  	09.1.1-12.31	  	
	 Common Dysosma Rhizome
	  		  	kg	  	6347	  	143.84	  	912,982.22	  	09.1.1-12.31	  	

 The Aggregate Value: RMB 5,172,073.63 

The Procurement Place: Yunnan Shangri-La Tibetan Medicine Group Co., Ltd. 

Date of Delivery: Delivery within 20 days upon the signature of the Contract 

Payment Method: Party A shall make payment of all the accounts payable within 10 days upon the entry of products in the warehouse and Party B shall draw
the accounts receivable by presentation of the warehouse voucher. 
 Quality Standard: State Standard 

Package: Polypropylene (PP) Knitted Bag or cloth bag free of any damage. 

Quality Requirements by Party B: The products shall comply with the state quality standards as well as the agreed quality standard bases on the said
quality standards; Packing Sound 
 Quality Requirements agreed by Both Parties: The Tibetan medicinal materials standard under the
administration authorities of the Ministry of Public Health shall be executed. 
 Liability of Breach: The breached party shall make the
compensation for the non-breach party by the amount equivalent to 30% of the aggregate value of the contract herein. 
 This contract is in
duplicate and shall be effective upon both parties’ signature, seal, and putting one’s fingerprint. 
 Party A: Yunnan Shangri-La
Tibetan Pharmaceutical Group Limited 
 Authorized Representative: Hong Yu (Signature): 

Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (Seal) 

Signature Date: Jan 6, 2009 
 Party B: Xiong Ba

 Authorized Representative: Xiong Ba (Signature): 

Signature Date: Jan 6, 2009
Exhibit 32.1
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and2.
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 By:
    
    /s/ Darl C. McBrideDarl C. McBridePresident and Chief Executive OfficerDate:
    
    March 2, 2009
IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON

DIVISION ONE

STATE OF WASHINGTON,

V.

RIVAS, BRIAN DAVID

DOB: 08/26/1992,

Respondent,

Appellant.

No. 77269-4-1

UNPUBLISHED OPINION

FILED: March 4, 2019

SCHINDLER, J. — A jury convicted Brian David Rivas of custodial assault. On July

27, 2017, the court sentenced Rivas to 25.5 months of confinement and ordered him to

pay the $500 victim assessment fee, $200 criminal filing fee, and $100 DNA1 collection

fee. Rivas challenges the imposition of the criminal filing fee and the DNA collection

fee. Because Rivas is indigent and the State previously collected a DNA fee, the State

concedes the criminal filing fee and the DNA collection fee should be stricken. We

accept the State's concession as well taken and remand to strike the criminal filing fee

and the DNA collection fee.

In 2018, the Washington State Legislature amended the legal financial obligation

statutes. LAWS OF 2018, ch. 269. The amended criminal filing fee statute states:

Upon conviction or plea of guilty, upon failure to prosecute an appeal from

a court of limited jurisdiction as provided by law, or upon affirmance of a

1 Deoxyribonucleic acid.
No. 77269-4-1/2

conviction by a court of limited jurisdiction, an adult defendant in a criminal

case shall be liable for a fee of two hundred dollars, except this fee shall

not be imposed on a defendant who is indigent as defined in RCW

10.101.010(3) (a) through (c).

RCW 36.18.020(2)(h).

The amended DNA collection fee statute states, in pertinent part:

Every sentence imposed for a crime specified in RCW 43.43.754 must

include a fee of one hundred dollars unless the state has previously

collected the offender's DNA as a result of a prior conviction.

RCW 43.43.7541.

In State v. Ramirez, 191 Wn.2d 732, 747, 426 P.3d 714 (2018), the Washington

Supreme Court held the 2018 amendments to the legal financial obligation statutes

apply to cases "pending on direct review and thus not final when the amendments were

enacted."

The State concedes that because Rivas was indigent at the time of sentencing

and his DNA has previously been collected as a result of a prior felony conviction, the

criminal filing fee and the DNA collection fee should be stricken. We accept the

concession and remand to strike the criminal filing fee and the DNA collection fee from

the judgment and sentence.

WE CONCUR:

2
[Federal Register Volume 61, Number 2 (Wednesday, January 3, 1996)]
[Notices]
[Pages 173-174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-00048]



=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on Reactor Safeguards Subcommittee Meeting on 
Thermal Hydraulic Phenomena

    The ACRS Subcommittee on Thermal Hydraulic Phenomena will hold a 
meeting on January 18 and 19, 1996, Room T-2B3, 11545 Rockville Pike, 
Rockville, Maryland.
    Most of the meeting will be closed to public attendance to discuss 
Westinghouse proprietary information pursuant to 5 U.S.C. 552b(c)(4).
    The agenda for the subject meeting shall be as follows:
    Thursday, January 18, 1996-8:30 a.m. until the conclusion of 
business.
    Friday, January 19, 1996-8:30 a.m. until the conclusion of 
business.
    The Subcommittee will continue its review of the Westinghouse best-
estimate ECCS Code, W COBRA/TRAC. The purpose of this meeting is to 
gather information, analyze relevant issues and facts, and to formulate 
proposed positions and actions, as appropriate, for deliberation by the 
full Committee. Oral statements may be presented by members of the 
public with the concurrence of the Subcommittee Chairman; written 
statements will be accepted and made available to the Committee. 
Electronic recordings will be permitted only during those portions of 
the meeting that are open to the public, and questions may be asked 
only by members of the Subcommittee, its consultants, and staff. 
Persons desiring to make oral statements should notify the cognizant 
ACRS staff engineer named below five days prior to the meeting, if 
possible, so that appropriate arrangements can be made.
    During the initial portion of the meeting, the Subcommittee, along 
with any of its consultants who may be 

[[Page 174]]
present, may exchange preliminary views regarding matters to be 
considered during the balance of the meeting.
    The Subcommittee will then hear presentations by and hold 
discussions with representatives of the NRC staff, the Westinghouse 
Electric Corporation, their consultants, and other interested persons 
regarding this review.
    Further information regarding topics to be discussed, whether the 
meeting has been cancelled or rescheduled, the scheduling of sessions 
which are open to the public, the Chairman's ruling on requests for the 
opportunity to present oral statements and the time allotted therefor 
can be obtained by contacting the cognizant ACRS staff engineer, Mr. 
Paul A. Boehnert (telephone 301/415-8065) between 7:30 a.m. and 4:15 
p.m. (EST). Persons planning to attend this meeting are urged to 
contact the above named individual one or two working days prior to the 
meeting to be advised of any potential changes in the proposed agenda, 
etc., that may have occurred.

    Dated: December 27, 1995.
Sam Duraiswamy,
Chief, Nuclear Reactors Branch.
[FR Doc. 96-00048 Filed 1-2-96; 8:45 am]
BILLING CODE 7590-01-P